The current stock performance of Arcturus Therapeutics shows a 52-week-high of $129.71 and a 52-week-low of $8.51. The price target for Sigilon Therapeutics is set to $45.00. The current stock performance of Sigilon Therapeutics shows a 52-week-high of $54.32 and a 52-week-low of $22.00. Arcturus Therapeutics closed at $92.42 at the end of the last trading period. The company was founded in 1967 and is based in Morrisville, North Carolina. Tenax Therapeutics Inc (TENX) - DEVELOPS THERAPEUTIC PRODUCTS FOR DISEASE INDICATION THAT REPRESENT SIGNIFICANT AREAS OF CLINICAL NEED. Tenax Therapeutics, Inc. (TENX), is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. A high-level overview of Marker Therapeutics, Inc. (MRKR) stock. The price target seems to have been set at $75.00 for Seer. Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary … Moreover, at the end of the last trading period, the closing price was at $10.96. United States, Tenax Therapeutics Reports First Quarter 2021 Results and Provides Business Update, Tenax Announces Publication Titled “Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the, Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand, Tenax Therapeutics Reports Fiscal Year 2020 Results and Provides Business Update, Tenax Therapeutics to Present at the H.C. Wainwright Global Life Sciences Virtual Conference, Tenax Therapeutics, Inc. At the end of the last trading period, Seer closed at $64.40. * Evercore ISI Group initiated coverage on BeyondSpring Inc (NASDAQ:BYSI) with an Outperform rating. The price target seems to have been set at $58.00 for Silverback Therapeutics. Caesarstone closed at $10.80 at the end of the last trading period. Analyzing The Upward Movement in BeyondSpring's Stock Today * Why Tenax Therapeutics's Stock is Trading Higher Today(C) 2020 Benzinga.com. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. BRIEF-Tenax Therapeutics Announces $8 Mln Registered Direct And Pipe Offerings Priced At-The-Market Under Nasdaq Rules Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. * SVB Leerink initiated coverage on Silverback Therapeutics Inc (NASDAQ:SBTX) with an Outperform rating. Find the latest news headlines from Tenax Therapeutics, Inc. Common Stock (TENX) at Nasdaq.com. EVP, Commercial and Business Operations at Tenax Therapeutics,Inc. Tenax Therapeutics develops treatments for treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF) using levosimendan. Arcturus Therapeutics closed at $92.42 at the end of the last trading period. Downgrades * For Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), Raymond James downgraded the previous rating of Outperform to Market Perform. © 2021 Verizon Media. The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. * With a Buy rating, HC Wainwright & Co. initiated coverage on Silverback Therapeutics Inc (NASDAQ:SBTX). Suite 490 MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the first quarter of 2021 and provided a … Seer closed at $64.40 at the end of the last trading period. Silverback Therapeutics closed at $36.50 at the end of the last trading period. Company Website. The stock has a 52-week-high of $2.68 and a 52-week-low of $0.25. About Tenax Therapeutics. At the moment, the stock has a 52-week-high of $17.31 and a 52-week-low of $14.30. Get the latest news and real-time alerts from Tenax Therapeutics, Inc. (TENX) stock at Seeking Alpha. Moreover, at the end of the last trading period, the closing price was at $39.80. * Benchmark initiated coverage on Porch Group Inc (NASDAQ:PRCH) with a Buy rating. * With an Overweight rating, JP Morgan initiated coverage on Seer Inc (NASDAQ:SEER). In addition to the average rating from Wall Street analysts, TENX … MORRISVILLE, N.C. (AP) _ Tenax Therapeutics Inc. (TENX) on Monday reported a loss of $23.7 million in its first quarter. Report this profile ... Business and Financial News that helps private and institutional investors make informed decisions and market study analyses. The Morrisville, North Carolina-based company said it had a … Benzinga does not provide investment advice. Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. Tenax Therapeutics Announces Late-Breaking Clinical Trial Presentation of Phase 2 HELP Study at Heart Failure Society of America (HFSA) Virtual Annual Scientific … * Jefferies initiated coverage on Sigilon Therapeutics Inc (NASDAQ:SGTX) with a Buy rating. The price target for Sigilon Therapeutics is set to $60.00. * Morgan Stanley initiated coverage on Sigilon Therapeutics Inc (NASDAQ:SGTX) with a Equal-Weight rating. The price target seems to have been set at $65.00 for Seer. The current stock performance of BeyondSpring shows a 52-week-high of $21.50 and a 52-week-low of $9.38. Expands Board of Directors, Tenax Therapeutics Schedules Conference Call to Discuss Its Transformative Acquisition of PH Precision Med, Tenax Therapeutics, Inc. * According to HC Wainwright & Co., the prior rating for Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) was changed from Buy to Neutral. Doug Randall CEO Advisor and Partner at The Trium Group. The price target for Tenax Therapeutics is set to $5.00. For the third quarter, Aprea Therapeutics had an EPS of $0.58, compared to year-ago quarter EPS of $5.29. The price target seems to have been set at $44.00 for Silverback Therapeutics. At the moment, the stock has a 52-week-high of $54.32 and a 52-week-low of $22.00. Tenax Therapeutics Inc. options quotes data for sells and puts, including TENX last price, change and volume. Snap, Barnes & Noble Education, U.S. Gold, Tenax Therapeutics and Pitney Bowes are five top gainers for Tuesday. At the end of the last trading period, Silverback Therapeutics closed at $36.50.See more from Benzinga * Click here for options trades from Benzinga * Why Is It Moving? * HC Wainwright & Co. initiated coverage on Tenax Therapeutics Inc (NASDAQ:TENX) with a Buy rating. The current stock performance of Continental Resources shows a 52-week-high of $36.20 and a 52-week-low of $6.90. For the third quarter, Arcturus Therapeutics had an EPS of $0.92, compared to year-ago quarter EPS of $0.56. * With a Equal-Weight rating, Morgan Stanley initiated coverage on Seer Inc (NASDAQ:SEER). At the moment, the stock has a 52-week-high of $15.86 and a 52-week-low of $7.65. The stock has a 52-week-high of $86.13 and a 52-week-low of $44.00. Sigilon Therapeutics closed at $39.80 at the end of the last trading period. The price target for Tenax Therapeutics is set to $5.00. Aprea Therapeutics closed at $5.50 at the end of the last trading period. Get Tenax Therapeutics Inc (TENX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. At the moment, the stock has a 52-week-high of $86.13 and a 52-week-low of $44.00. Raleigh-Durham, North Carolina Area. ... BROOKFIELD NEWS, April 07, 2021 (GLOBE NEWSWIRE) -- Brookfield Asset Management Inc. (“Brookfield”) (TSX: BAM.A, NYSE: BAM) … * Baird downgraded the previous rating for Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) from Outperform to Neutral. Recent News. Morrisville, NC 27560 1 Copley Parkway The stock has a 52-week-high of $225.89 and a 52-week-low of $93.92. * With a Buy rating, Stifel initiated coverage on Silverback Therapeutics Inc (NASDAQ:SBTX). ... Latest News. Tenax Therapeutics Inc stock has gained 210.00% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives TENX stock a score of 69 out of a possible 100.. That rank is influenced by a fundamental score of 88. At the end of the last trading period, Tenax Therapeutics closed at $1.07. While Tenax Therapeutics didn’t issue any news this morning, the company didn’t have to. Silverback Therapeutics closed at $36.50 at the end of the last trading period. Announces Transformative Acquisition of PH Precision Med, Braingrid Limited Announces Changes to Board of Directors, Orion Oyj: Orion Group Interim Report January-March 2015. Upgrades * For Continental Resources Inc (NYSE:CLR), KeyBanc upgraded the previous rating of Sector Weight to Overweight. At the moment, the stock has a 52-week-high of $36.70 and a 52-week-low of $24.22. All rights reserved. Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders. 5. Tenax Therapeutics, Inc. (TENX), is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. Dow Jones, a News Corp company About WSJ. * HC Wainwright & Co. initiated coverage on Tenax Therapeutics Inc (NASDAQ:TENX) with a Buy rating. At the moment, the stock has a 52-week-high of $36.70 and a 52-week-low of $24.22. The price target for Porch Group is set to $24.00. The Company develops and commercializes products for the critical care market. Latest Trade. Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the first quarter of 2021 and provided a business update. Tenax Therapeutics, Inc. operates as a specialty pharmacuitical company. Tenax Therapeutics … It was picked up by an analyst, causing all of the excitement we’re seeing this morning. The Company develops and commercializes products for the critical care market. * For Aprea Therapeutics Inc (NASDAQ:APRE), RBC Capital downgraded the previous rating of Outperform to Sector Perform. At the end of the last trading period, Splunk closed at $175.55. Currency in USD, Trade prices are not sourced from all markets. Tenax Therapeutics Inc. TENX.O. Moreover, at the end of the last trading period, the closing price was at $92.42. New Stories. At the moment, the stock has a 52-week-high of $129.71 and a 52-week-low of $8.51. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real Time Price. Financial summary and company information for Tenax Therapeutics Inc TENX ... U.S. News has analyzed over 4,500 stocks to help investors reach their financial goals. At the moment, the stock has a 52-week-high of $86.13 and a 52-week-low of $44.00. Tenax Therapeutics Inc. (TENX) on Monday reported a loss of $23.7 million in its first quarter. : 262593535 | State of Incorp. Tenax Therapeutics to Present at the H.C. Wainwright Global Life Sciences Virtual Conference Provided by Business Wire Mar 4, 2021 1:30 PM UTC Business Wire For the third quarter, Arcturus Therapeutics had an EPS of $0.92, compared to year-ago quarter EPS of $0.56. Tenax shares rose after the company reported progress in a Phase 2 study of levosimendan to treat pulmonary hypertension and heart failure. TENAX THERAPEUTICS, INC. (Subject) CIK: 0000034956 (see all company filings) IRS No. Initiations * Daiwa Capital initiated coverage on Splunk Inc (NASDAQ:SPLK) with a Neutral rating. In the third quarter, Tenax Therapeutics showed an EPS of $0.18, compared to $0.33 from the year-ago quarter. Doug Randall. Get the latest Tenax Therapeutics Inc (TENX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. The price target for BeyondSpring is set to $30.00. The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. Moreover, at the end of the last trading period, the closing price was at $16.26. All rights reserved. At the moment, the stock has a 52-week-high of $53.11 and a 52-week-low of $5.35. Seer closed at $64.40 at the end of the last trading period. The stock has a 52-week-high of $36.70 and a 52-week-low of $24.22. In the third quarter, Caesarstone showed an EPS of $0.41, compared to $0.29 from the year-ago quarter. Tenax Therapeutics, Inc, a specialty pharmaceutical company, focuses on identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. In the third quarter, Tenax … * For Caesarstone Ltd (NASDAQ:CSTE), Benchmark initiated coverage, by setting the current rating at Buy. BRIEF-Tenax Therapeutics Inc Announced Publication Of Positive Data From Co's Phase 2 Help Study Reuters 4/9/2021. In the third quarter, Arcturus Therapeutics showed an EPS of $0.92, compared to $0.56 from the year-ago quarter. At the moment, the stock has a 52-week-high of $129.71 and a 52-week-low of $8.51. * For Seer Inc (NASDAQ:SEER), Cowen & Co. initiated coverage, by setting the current rating at Outperform. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. In the third quarter, Splunk showed an EPS of $0.07, compared to $0.58 from the year-ago quarter. Porch Group closed at $14.71 at the end of the last trading period. Continental Resources earned $0.16 in the third quarter, compared to $0.54 in the year-ago quarter. In the third quarter, BeyondSpring showed an EPS of $0.48, compared to $0.37 from the year-ago quarter. Tenax Therapeutics, Inc. operates as a specialty pharmacuitical company.

Tartine De Rouget, Brain Série Netflix, Fait Le Reste Synonyme, Ornemental Mots Fléchés, Sac Ski De Rando Decathlon, New Crypto Listing, Autorisation Piscine En Zone Agricole, Réglementation Abri De Jardin Voisinage 2020, Dalle Terrasse Sur Plot 60x60 Leroy Merlin,